Al-AqeelARashedMOzandPT: 3-Methylglutaconic aciduria: Ten new cases with a possible new phenotype [comment]. Brain & Development16: 32, 1994.
2.
ArbelaezACastilloMStoneJ: MRI in 3-Methylglutaconic aciduria type 1. Neuroradiology41: 941–942, 1999.
3.
BaethmannMWendelUHoffmannGF: Hydrocephalus internus in two patients with 5,10-methylenetetrahydrofolate reductase deficiency.[comment]. Neuropediatrics31: 314–317, 2000.
4.
BrismarJAqeelABrismarG: Maple syrup urine disease: Findings on CT and MR scans of the brain in 10 infants. Am J Neuroradiol11: 121–128, 1990.
5.
BroideEElpelegOLahatE: Type IV 3-methylglutaconic (3-MGC) aciduria: A new case presenting with hepatic dysfunction. Pediatric Neurology17: 353–355, 1997.
6.
CavalleriFBerardiABurlinaAB: Diffusion-weighted MRI of maple syrup urine disease encephalopathy. Neuroradiology44: 499–502, 2002.
7.
ChitayatDChemkeJGibsonKM: 3-Methylglutaconic aciduria: A marker for as yet unspecified disorders and the relevance of prenatal diagnosis in a ‘new’ type (‘type 4’). Journal of Inherited Metabolic Disease15: 204–212, 1992.
8.
ChoiCGYooHW: Localized proton MR spectroscopy in infants with urea cycle defect. Am J Neuroradiol22: 834–837, 2001.
9.
D'IncertiLFarinaLMoroniI: L-2-Hydroxyglutaric aciduria: MRI in seven cases. Neuroradiology40: 727–733, 1998.
10.
FentonBWLinCMacedoniaC: The fetus at term: In utero volume-selected proton MR spectroscopy with a breath-hold technique-afeasibility study. Radiology219: 563–566, 2001.
11.
HamiltonRLHaasRHNyhanWL: Neuropathology of propionic acidemia: A report of two patients with basal ganglia lesions. Journal of Child Neurology10: 25–30, 1995.
12.
JanWZimmermanRAWangZJ: MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation. Neuroradiology45: 393–399, 2003.
13.
KokRDvan den BerghAJHeerschapA: Metabolic information from the human fetal brain obtained with proton magnetic resonance spectroscopy. American Journal of Obstetrics and Gynecology185: 1011–1015, 2001.
14.
NowaczykMJBlaserSIClarkeJT: Central nervous system malformations in ethylmalonic encephalopathy. American Journal of Medical Genetics75: 292–296, 1998.
15.
CerdáPérez CMerineroBMartíM: An unusual late-onset case of propionic acidaemia: Biochemical investigations, neroradiological findings and mutation analysis. Eur J Pediatr157: 50–52, 1998.
16.
PressGABarshopBAHaasRH: Abnormalities of the brain in nonketotic hyperglycinemia: MR manifestations. Am J Neuroradiol10: 315–321, 1989.
17.
TopcuMErdemGSaatciI: Clinical and magnetic resonance imaging features of L-2-hydroxyglutaric acidemia: Report of three cases in comparison with Canavan disease. Journal of Child Neurology11: 373–377, 1996.
18.
TzikaAABallWSJr.VigneronDB: Clinical proton MR spectroscopy of neurodegenerative disease in childhood. Am J Neuroradiol14: 1267–1264, 1993.
19.
UzielGSavoiardoMNardocciN: CT and MRI in maple syrup urine disease. Neurology38: 486–488, 1988.
20.
Vion-DuryJMeyerhoffDJCozzonePJ: What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy. J Neurol241: 354–371, 1994.
21.
YalcinkayaCDincerAGündüzE: MRI and MRS in HMG-CoA lyase deficiency. Pediatric Neurology20: 375–380, 1999.
